Pharmaceutical preparations for treating metabolic disorders; Pharmaceutical preparations for treating fibrotic disorders; pharmaceutical preparations for treating mitochondrial disease; pharmaceutical preparations for treating NAFLD and NASH disease and related disorders; pharmaceuticals for treating genetic disorders; pharmaceuticals for treating neurological disorders; and pharmaceuticals for treating Huntington's disease and related disorders